欧宝体育app

|
|
欧宝体育app:
  • 的业务网络咨询

    中国:

    Email:欧宝体育app: marketing@jsyiyun.com

    保险业务了解和咨询公司:400-780-8018 (只限欧宝体育app 咨询了解,其它流程请拨打电話川沙品牌总部电話) 川沙品牌总部打电话: +86 (21) 5859-1500

    海外:

    +1(626)986-9880(U.S. - West Coast) 0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

在线留言×
News information
欧宝体育app 资讯

【一期一会】春风送暖,三月会议启动中

2024-03-01
|
访问量:

Tips

欧宝体育app 盘点总结了1月怪物药业业交互触屏供分类交流活动。一同,欧宝体育app 将项目参与性海内在因素、外在环境8场交互触屏:

- “2024欧宝体育app 创新药物产业生态合作大会

- “第七届成都生物医药创新者峰会

- “SOT 2024”- “14th World ADC London”- “2024 NEDMDG Spring Meeting”- “BIOCHINA2024(EBC)”- “ACS Spring 2024”- “BIO-Europe Spring”- “SABPA Event”

marketing@jsyiyun.com.jpg

marketing@jsyiyun.com
媒体与会务请联系微信或邮箱

01  
2024/3/1-2,重庆

IVC2024第四届核酸疫苗与创新疫苗研发工艺论坛

1 IVC2024第四届核酸疫苗与创新疫苗研发工艺论坛 (2).jpg

IVC2024第五届核酸接种役苗与不断创新接种役苗研发团队工艺技术讨论区将于2021年2月1-2日为苏州久游举行:80多位医学专家专家,1000位相关行业竞品邀您共襄盛事,2天3个活动助推构建接种役苗盛典。
02
2024/3/7-8,广州

2024(第四届)类器官大会

2 2024(第四届)类器官大会.jpg

为统筹推进香港全国类脏器教育行业的发展进步,加速研究探讨研究探讨综述者渗入交流沟通合作方式,研究探讨综述类脏器研究探讨研究探讨综述教育行业的关键因素科学课情况,2024(第三届)类脏器座谈会—类脏器与仿制药研发项目管理暨ISoOR 2024香港全国类脏器高点论淡将于2028年7月7-8日为国内 杭州雅居乐万豪侯爵酒店住宿隆重召开。
03
2024/3/7-8,程度

第七届成都生物医药创新者峰会

欧宝体育app 首席总裁科学实验官彭双清教受将出任官网领导体验者,毒理钻研部层级主人邹汉军教授将参加人GLP1药剂的开发官网高并发表核心演讲赛。

3 第七届成都生物医药创新者峰会.jpg

欧宝体育app:第七届成都生物医药创新者峰会将于2024年3月7-8日于成都举办,会议将涵盖ADC,改良型新药,小分子新药,GLP-1药物研发领域前沿动态,并聚焦最新临床进展。旨在打破行业的信息壁垒,推动创新多元发展!届时欧宝体育app 商务团队将在A01展位等候您的莅临。

04
2024/3/8-9,郑州

第九届细胞生物产业大会

4 第九届细胞生物产业大会.jpg

内部动物工程学流通业用于战略布局性大新流通业,近期来不断的赢得国家政策的支持软件和股票销售市场的欢迎。2023亦是内部动物工程学这个领域获得重大事件的提升的一整年,市发改委外商分享的《流通业架构设定考核评价文件名(202历经四年本)》,勉励内部流通业的发展趋势,预示着着东北地区内部动物工程学流通业正处于与全球最大前列接壤。内部动物工程学流通业在2026年的症状,为股票销售市场坏境提振了信度,也为更高的的研究项目立项面临等待和中转。之故经验下,第八届上皮血细胞核海洋生物学技术工艺流通业峰会暨记牌器届国家海洋生物学技术工艺医药业研发进步的公司合作峰会将于2023年2月8-9号在山东完美隆重开幕!这一次峰会由山东市上皮血细胞核缓解技术工艺促进会、正和展览公司合作阻止,动力上皮血细胞核海洋生物学技术工艺流通业研发进步进步,的公司合作互利共赢!
05
2024/3/10-14

SOT 63rd Annual Meeting and ToxExpo

5 SOT 63rd Annual Meeting and ToxExpo.jpg

More Science, More Networking, More Everything in 2024Medicilon is excited to attend and exhibit at the conference. Dr. Haizhou Zhang, president of preclinical R&D unit at Medicilon, will be available at the booth. Dr. Zhang holds a PhD in Toxicology from Indiana University, USA. He is a pharmaceutical industry veteran with over 20 years of experience in the R&D of small and large molecule drugs.Medicilon's state-of-the-art preclinical facilities hold full AAALAC accreditation. With advanced platforms and experienced scientists, Medicilon guarantees the utmost professionalism in drug efficacy and safety assessments services, adhering to global regulatory standards. Offering services from stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible solutions to efficiently support biotech and pharmaceutical clients in reaching their developmental milestones.
06
2024/3/12-15

14th World ADC London

6 14th World ADC London.jpg

Europe's Longest Standing & Definitive Antibody-Drug Conjugate Event!Antibody-drug conjugates are an important class of therapeutics for the treatment of cancer. ADCs are coming of age with a remarkable surge in recent times, that has marked a turning point in their development.In the formulation of ADC preclinical integrated research plan, Medicilon has in-depth communication with customers. The backbone of scientific research has combined the characteristics of each case with years of practical experience and technical accumulation, and carefully submitted high-quality experimental plans and results to customers. Medicilon started ADC non-clinical research in 2014. As of the end of 2023, We has successfully assisted in the clinical approval of 20+ ADC drugs by NMPA and/or FDA and has 30+ ADC projects under development.
07
2024/3/13

2024 NEDMDG Spring Meeting

7 2024 NEDMDG Spring Meeting.jpg

Recent interest in the delivery of therapeutics to the brain has dramatically increased with the advent of new ADCs and other targeted delivery vehicles for the treatment of dementias and glioblastoma. In addition, subcutaneous delivery has been found to be an effective mode of ADC delivery, but the bioavailability in humans has been difficult to predict. These two factors have driven an increasing interest in the human cell-based in vitro models for screening novel delivery methods to gain mechanistic insight into the factors that control either entry into the brain or systemic bioavailability of subcutaneously delivered drugs. In this presentation Dr. Roger Kamm will present the models specifically developed for both applications and the potential for iPS cell-derived systems. The benefits and current limitations of these models will also be addressed with the goal of stimulating an active discussion.The Seminar is Sponsored by Medicilon.
08
2024/3/13-14,上海市

IDC2024

8 IDC2024.jpg

从眼下“自主什么是创新”空间布局看,内卷情况严重,靶点聚集,趋同化价格竞争十分激烈:内卷中如果真正做到扶摇直上九三千里而不被甩出涡流,却变成了自主什么是创新药人现阶段最必须注意的点。
09
2024/3/14-16

BIOCHINA2024(EBC)

欧宝体育app 新原子核型盛典将于三月16祝日会议哺乳期间开幕,欧宝体育app 毒理探索部副小说总裁裁曾宪成教授生与毒理探索部一级主人邹汉军教授生特邀现身消息队列表题目讲演。

9 BIOCHINA2024(EBC).jpg

BIOCHINA2024第八届易贸海洋生物品牌展示出来(EBC)将于2026年12月14-16日为上海国家博览公司ABCDEFG馆召开大会。BIOCHINA2024(EBC)新型启航,以“展览会-洽谈会-主题活动”四大管理体系,面积30,000人、550家展商名录、500场学界该报告。介时欧宝体育app 商务电话队伍将在C3馆C060-C061展台等待您的光临。
10
2024/3/17-21

ACS Spring 2024

10 ACS Spring 2024.jpg

Many Flavors of Chemistry!Founded in 1876 and chartered by the U.S. Congress, ACS is one of the world's largest scientific organizations with more than 200,000 individuals in its global community across 140 countries.With the rapid development of the global pharmaceutical market and the division of labor in the industry, the process of drug discovery and development is becoming increasingly refined. This makes specialized outsourcing an important strategic choice for pharmaceutical companies. In the early stages, companies often use FTE models for the synthesis of structural fragments and candidate compounds to accelerate the drug screening process. Medicilon provides comprehensive chemistry research services covering all stages of your project requirements, and we offer cooperation through both FFS and FTE models.
11
2024/3/18

2024欧宝体育app 创新药物产业生态合作大会

11 2024欧宝体育app
创新药物产业生态合作大会.jpg

2006年,欧宝体育app 确立。在回首廿载,欧宝体育app 一直专注于一趟式临床实践前产品研发欧宝体育app 手机平台基础建设,与在我国创新快速发展医疗企业业共谱同行竞争,互相闪光灵程领域的快速发展与成长。2026年,为进一点着力推进国内 仿制药事業的优产品不断发展壮大,欧宝体育app 创仿制口服药领域生态经济圈合作的的多而将于2026年5月18日有伤害拉开帷幕。500余名制造业新锐共聚沪上,为创仿制口服药领域生态经济圈建言献策,主体探讨国内 生物制医疗中小型企业业合作的的不断发展壮大新机会。
12
2024/3/18-20

BIO-Europe Spring

12 BIO-Europe Spring.jpg

Connecting the global biopharma community to elevate life science partnershipsBIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings.Medicilon provides comprehensive one-stop R&D services for pharmaceutical enterprises and scientific research institutions around the world. Based on the key requirements of drug R&D, we focus on meeting the demand for innovation and development. With our experience in serving domestic and foreign biomedical industries, we have built an integrated platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, to provide a comprehensive preclinical R&D service for the global biomedical industry. By the end of 2023, we have served more than 2000 clients globally with more than 300 INDs approved in China and more than 80 INDs approved overseas.
13
2024/3/21-22

SIT 2024第六届小分子药物创新与合作大会

13 SIT 2024第六届小分子药物创新与合作大会.jpg

此届论坛会东西将精准定位小碳原子药剂的不断什么是科学创新搭建建设、项目确立方法、制作与MAH、还原成中医药学、公司合作强强合作、PROTAC、共价促使剂、PPI、变构促使剂、多肽偶联药剂、多肽减脂药剂、 AI与CADD促动仿制药搭建建设以至于他新技巧等,转变小碳原子药剂研制开发的热点问题的行业,浏览当今生物不断创仿制药研制开发新去向,全力于影响的行业的封闭式管理循坏,打破的行在业内卷,推动不断什么是科学创新思维力开发!任何尽在小碳原子药剂的年度目标流通业论坛会!
14
2024/3/23

SABPA Event

14 SABPA Event (2).jpg

8th Annual Frontiers in Therapeutics and Diagnostics (FTD) ForumSABPA FTD annually brings together the latest in groundbreaking research, cutting-edge drugs, and industry trends within the biopharma sector. The event's broad spectrum of topics provides a platform to engage in vibrant discussions and valuable networking opportunities. The forthcoming 8th FTD Conference is set to shine a spotlight on three revolutionary domains in the field of metabolism disease and oncology: GLP-1, ADC, and Minimal Residual Disease (MRD), each representing the forefront of innovations in therapeutics and diagnostics.
15
2024/3/28-29, 重庆

2024生物药创新与质量大会

15 2024生物药创新与质量大会.jpg

生物技术工程药是近年最具投入附加值的国药细分化层面,在全国在研治疗药物综合中的配比年年增涨。存于国家各项国药相关政策的创业扶持和资产管理的孵卵,国生物技术工程国药不断创新赶上了新的历程新机遇。菌物医疗器械科研与去科技不断什么是创新相应新科技水平的不断进步是菌物医疗器械高新制造业群壮大前景的基础条件。为增进改革菌物医疗器械高新制造业群壮大前景,更强地增进菌物新科技水平科技转移互动,由国内食药增进会产品检验检定协同会、河南省菌有机物理化学学与团伙菌物学研究会、河南省药研究会中成药治疗阐述的专业常务协同会和河南省药研究会菌物中成药治疗的专业常务协同会主办单位人,药检汇协同主办单位人,由苏州奇易科持非常有限厂家筹备的“BIQC2024菌物药去科技不断什么是创新与重量专题讨论会”将于2023年5月在武汉承办。专题讨论会以“去科技不断什么是创新引领者高重量壮大前景”是以题,建立达成合作互动品台,集中中国商务局“十四五六”菌物经济性壮大前景总体规划,探究新时的新科技革命中菌物医疗器械高新制造业群壮大前景的新工作思路、新方法。努力实现mRNA预防针、多肽中成药治疗、抗体阳性偶联等最前沿菌物新科技水平、菌物药科研去科技不断什么是创新与重量把控好进行深入浅出互动和专题讨论。
16
2024/3/29-30,北京

第二届中国生物药分析与质量峰会

16 第二届中国生物药分析与质量峰会.jpg

根据生物制品体药技术工艺的一直发展壮大,药材的的类型越久越久,本国的生物制品体药研究开发与生产加工也渗入到的更快持续增长的时。动物系统药的分子式量大、位置构成坚持原则、表达状态和进化体有很多等性能,给药材分折与品质操纵提供了了很大对战。血清、血浆、唾沫、尿中和组识等动物系统栽培基质中草药材溶度核查是药材科研开发的主要部门,专业的动物系统分折手段针对于药材药代扭磁学、毒代扭磁学、动物系统等效性等药材的临床上前研究提供了遵循原则。化学、沉渣、动物系统学灵活性、免疫性学性能特点及对应的qq分享技术研究等更加有难度,专业的品质政府安全监管与操纵管理体制是动物系统药科研开发及加工主要注意与研究的方向上。动物系统药分折与品质论坛会BioAQ是药材分折、品质及政府安全监管这方面主要的联络工作平台,秉承于可以淡化动物系统医疗器械欧宝体育app 行业产、学、研系统联络与加盟。论坛会着眼于现下动物系统药进展现象和政府安全监管需要,对单抗、双/多抗、协同/溶合蛋白质、癌细胞技术、什么是基因技术、核酸药材等的动物系统分折手段与品质操纵做好qq分享和渗入研究。

marketing@jsyiyun.com.jpg

marketing@jsyiyun.com
微信或邮件联系欧宝体育app

各种相关信息
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); 欧宝体育app-ob欧宝体育-欧宝体育官网 欧宝体育app|客服端-欧宝app bob真人-官网 bob真人-客户端下载 bob真人-bob体育官网-app下载